Molecular identification and characterization of three isoforms of tachykinin NK1-like receptors in the cane toad Bufo marinus

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 287, Issue 3 56-3, 2004, Pages

  Liu, Lu ^a   Markus, Irit ^a   Vandenberg, Robert J ^b   Neilan, Brett A ^a   Murray, Michael ^a   Burcher, Elizabeth ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b University of Sydney   (Australia)

Author keywords

Amphibian; Bufokinin; Sequencing and cloning; Tachykinin receptors; Xenopus oocyte expression

Indexed keywords

AMINO ACID; BOLTON HUNTER REAGENT I 125; BUFOKININ; ISOPROTEIN; NEUROKININ 1 RECEPTOR; NEUROKININ A; SUBSTANCE P; TACHYKININ; TACHYKININ RECEPTOR; UNCLASSIFIED DRUG;

ALTERNATIVE RNA SPLICING; AMINO ACID SEQUENCE; AMPHIBIA; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BRAIN; CARBOXY TERMINAL SEQUENCE; CARDIOVASCULAR SYSTEM; CELL STRAIN COS7; CHLORIDE CURRENT; CONTROLLED STUDY; FEMALE; HUMAN; INTESTINE; LUNG; MALE; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RADIOASSAY; RECEPTOR DOWN REGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKELETAL MUSCLE; SPINAL CORD; TISSUE SPECIFICITY; TOAD; XENOPUS;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; BINDING, COMPETITIVE; BUFO MARINUS; CERCOPITHECUS AETHIOPS; CLONING, MOLECULAR; COS CELLS; FEMALE; LIGANDS; MALE; MOLECULAR SEQUENCE DATA; OOCYTES; PROTEIN ISOFORMS; RECEPTORS, NEUROKININ-1; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSFECTION; XENOPUS LAEVIS;

EID: 4143056805     PISSN: 03636119     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpregu.00051.2004     Document Type: Article

References (39)

1. Baker SJ, Morris JL, and Gibbins IL. Cloning of a C-terminally truncated NK-1 receptor from guinea-pig nervous system. Brain Res Mol Brain Res 111: 136-147, 2003.
2. Buck SH. The Tachykinin Receptors. Totowa, NJ: Humana, 1994.
3. Burcher E and Warner FJ. Tachykinin receptors in the small intestine of the cane toad (Bufo marinus): a radioligand binding and functional study. Naunyn Schmiedebergs Arch Pharmacol 357: 692-700, 1998.
4. Caberlotto L, Hurd YL, Murdock P, Wahlin JP, Melotto S, Corsi M, and Carletti R. Neurokinin 1 receptor and relative abundance of the short and long isoforms in the human brain. Eur J Neurosci 17: 1736-1746, 2003.
5. Cascieri MA, Fong TM, and Strader CD. Molecular characterization of a common binding site for small molecules within the transmembrane domain of G-protein coupled receptors. J Pharmacol Toxicol Methods 33: 179-185, 1995.
6. Conlon JM, Warner FJ, and Burcher E. Bufokinin: a substance P-related peptide from the gut of the toad, Bufo marinus with high binding affinity but low selectivity for mammalian tachykinin receptors. J Peptide Res 51: 210-215, 1998.
7. Debeljuk L, Rao JN, and Bartke A. Tachykinins and their possible modulatory role on testicular function: a review. Int J Androl 26: 202-210, 2003.
8. Dietl MM and Palacios JM. Phylogeny of tachykinin receptor localization in the vertebrate central nervous system: apparent absence of neurokinin-2 and neurokinin-3 binding sites in the human brain. Brain Res 539: 211-222, 1991.
9. Fong TM, Anderson SA, Yu H, Huang RC, and Strader CD. Differential activation of intracellular effector by two isoforms of human neurokinin-1 receptor. Mol Pharmacol 41: 24-30, 1992.
10. Fong TM, Huang RC, and Strader CD. Localization of agonist and antagonist binding domains of the human neurokinin-1 receptor. J Biol Chem 267: 25664-25667, 1992.
11. Fong TM, Yu H, Huang RC, and Strader CD. The extracellular domain of the neurokinin-I receptor is required for high-affinity binding of peptides. Biochemistry 31: 11806-11811, 1992.
12. Gerard NP, Eddy Shows TB RL Jr, and Gerard C. The human neurokinin A (substance K) receptor. Molecular cloning of the gene, chromosome localization, and isolation of cDNA from tracheal and gastric tissues. J Biol Chem 265: 20455-20462, 1990.
13. Harrison S, and Geppetti P. Substance P. Int J Biochem Cell Biol 33: 555-576, 2001.
14. Hershey AD, Dykema PE, and Krause JE. Organization, structure, and expression of the gene encoding the rat substance P receptor. J Biol Chem 266: 4366-4374, 1991.
15. Holmgren S and Jensen J. Evolution of vertebrate neuropeptides. Brain Res Bull 55: 723-735.
16. Holst B, Hastrup H, Raffetseder U, Martini L, and Schwartz TW. Two active molecular phenotypes of the tachykinin NK1 receptor revealed by G-protein fusions and mutagenesis. J Biol Chem 276: 19793-19799, 2001.
17. Huang RC, Huang D, Strader CD, and Fong TM. Conformational compatibility as a basis of differential affinities of tachykinins for the neurokinin-1 receptor. Biochemistry 34: 16467-16472, 1995.
18. Huang RC, Yu H, Strader CD, and Fong TM. Interaction of substance P with the second and seventh transmembrane domains of the neurokinin-I receptor. Biochemistry 33: 3007-3013, 1994.
19. Kawada T, Furukawa Y, Shimizu Y, Minakata H, Nomoto K, and Satake H. A novel tachykinin-related peptide receptor. Sequence, genomic organization, and functional analysis. Eur J Biochem 269: 4238-4146, 2002.
20. Krause JE, Bu JY, Takeda Y, Blount P, Raddatz R, Sachais BS, Chou KB, Takeda J, McCarson K, and DiMaggio D. Structure, expression and second messenger-mediated regulation of the human and rat substance P receptors and their genes. Regul Pept 46: 59-66, 1993.
21. Liu L, Shang F, Perry MA, Comis A, and Burcher E. Bufokinin: immunoreactivity, receptor localization and actions in toad intestine and mesenteric circulation. Peptides 21: 1345-1354, 2000.
22. Liu L, Warner FJ, Conlon JM, and Burcher E. Pharmacological and biochemical investigation of receptors for the toad gut tachykinin peptide, bufokinin, in its species of origin. Naunyn Schmiedebergs Arch Pharmacol 360: 187-195, 1999.
23. McConalogue K, Dery O, Lovett M, Wong H, Walsh JH, Grady EF, and Bunnett NW. Substance P-induced trafficking of β-arrestins. The role of β-arrestins in endocytosis of the neurokinin-1 receptor. J Biol Chem 274: 16257-16268, 1999.
24. Miledi R and Parker I. Chloride current induced by injection of calcium into Xenopus oocytes. J Physiol 357: 173-183, 1984.
25. Nakajima Y, Tsuchida K, Negishi M, Ito S, and Nakanishi S. Direct linkage of three tachykinin receptors to stimulation of both phosphatidylinositol hydrolysis and cyclic AMP cascades in transfected Chinese hamster ovary cells. J Biol Chem 267: 2437-2442, 1992.
26. Oakley RH, Laporte SA, Holt JA, Barak LS, and Caron MG. Molecular determinants underlying the formation of stable intracellular G protein-coupled receptor-β-arrestin complexes after receptor endocytosis. J Biol Chem 276: 19452-19460, 2001.
27. Pennefather JN, Lecci A, Candenas ML, Patak E, Pinto FM, and Maggi CA. Tachykinins and tachykinin receptors: a growing family. Life Sci 74: 1445-1463, 2004.
28. Reale V, Hannan F, Hall LM, and Evans PD. Agonist-specific coupling of a cloned Drosophila melanogaster D1-like dopamine receptor to multiple second messenger pathways by synthetic agonists. J Neurosci 17: 6545-6553, 1997.
29. Rosenkilde MM, Cahir M, Gether U, Hjorth SA, and Schwartz TW. Mutations along transmembrane segment II of the NK-1 receptor affect substance P competition with non-peptide antagonists but not substance P binding. J Biol Chem 269: 28160-28164, 1994.
30. Sasakawa N, Sharif M, and Hanley MR. Attenuation of agonist-induced desensitization of the rat substance P receptor by progressive truncation of the C-terminus. FEBS Lett 347: 181-184, 1994.
31. Severini C, Improta G, Falconieri-Erspamer G, Salvadori S, and Erspamer V. The tachykinin peptide family. Pharmacol Rev 54: 285-322, 2002.
32. Simmons MA, Brodbeck RM, Karpitskiy VV, Schneider CR, Neff DP, and Krause JE. Molecular characterization and functional expression of a substance P receptor from the sympathetic ganglion of Rana catesbeiana. Neuroscience 79: 1219-1229, 1997.
33. Takahashi K, Tanaka A, Hara M, and Nakanishi S. The primary structure and gene organization of human substance P and neuromedin K receptors. Eur J Biochem 204: 1025-1033, 1992.
34. Tillett D, Burns BP, and Neilan BA. Optimized rapid amplification of cDNA ends (RACE) for mapping bacterial mRNA transcripts. Biotechniques 28: 448-456, 2000.
35. Torfs H, Oonk HB, Broeck JV, Poels J, Van Poyer W, De Loof A, Guerrero F, Meloen RH, Akerman K, and Nachman RJ. Pharmacological characterization of STKR, an insect G protein-coupled receptor for tachykinin-like peptides. Arch Insect Biochem Physiol 48: 39-49, 2001.
36. Torfs H, Shariatmadari R, Guerrero F, Parmentier M, Poels J, Van Poyer W, Swinnen E, De Loof A, Akerman K, and Vanden Broeck J. Characterization of a receptor for insect tachykinin-like peptide agonists by functional expression in a stable Drosophila Schneider 2 cell line. J Neurochem 74: 2182-2189, 2000.
37. Vandenberg RJ, Mitrovic AD, Chebib M, Balcar VJ, and Johnston GA. Contrasting modes of action of methylglutamate derivatives on the excitatory amino acid transporters, EAAT1 and EAAT2. Mol Pharmacol 51: 809-815, 1997.
38. Yamamoto M, Okumura S, Schwencke C, Sadoshima J, and Ishikawa Y. High efficiency gene transfer by multiple transfection protocol. Histochem J 31: 241-243, 1999.
39. Zhang L, Sports CD, Osawa S, and Weiss ER. Rhodopsin phosphorylation sites and their role in arrestin binding. J Biol Chem 272: 14762-14768, 1997.